Egypt
Industry
BMI View: A minor downgrade of Egypt's credit rating will not have a significant impact on the cost of borrowing for local drugmakers and subsequent overall cost of pharmaceutical...
2013-05-13Industry
BMI View: Geographic diversification and investment into the pharmaceutical and healthcare sector of emerging economies such as Egypt looks to be a favourable strategy for any multinational...
2013-03-22Industry
BMI View: The patent cliff has led to a flood of generic drugs into the global pharmaceutical market, resulting in downward pressure on generic drug prices and increasing competition...
2013-01-11Industry
BMI View: Egypt's public healthcare system has traditionally targeted the country's urban population, leaving those on low incomes in remote areas with a slim chance of obtaining basic...
2012-12-14Industry
BMI View: As anticipated by BMI, Egyptian President Mohammad Mursi's relative success in his first 100 days in office highlights a degree of political and economic stability, which...
2012-10-18Industry
BMI View: We maintain our view that as long as political and economic instability shake Egypt, there will be no resolution of the ongoing drug pricing dispute between the government,...
2012-09-04Industry
BMI View: The Egyptian government's implementation of an international drug-price referencing system, and its recent amendment of it, without regarding stakeholders' proposals, has...
2012-07-19Industry
BMI View: Egypt wants to introduce hospital public-private partnerships (PPPs), which should deliver efficiency savings and better healthcare outcomes, and reduce capital outflows due...
2012-06-21




